We are live on ! Find out more
AGM

Alpine Global Management Portfolio holdings

AUM $668M
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+3.92%
1 Year Est. Return
+20.22%
3 Year Est. Return
+100.14%
5 Year Est. Return
+103.13%
10 Year Est. Return
+677.44%
AUM
$440M
AUM Growth
+$94.2M
Cap. Flow
+$94.5M
Cap. Flow %
21.49%
Top 10 Hldgs %
58.18%
Holding
313
New
120
Increased
42
Reduced
18
Closed
130

Sector Composition

Rank Sector Weight
1 Communication Services 30.84%
2 Technology 13.69%
3 Materials 6.97%
4 Healthcare 5.43%
5 Financials 4.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPMC
126
DELISTED
Blueprint Medicines
BPMC
$226K 0.05%
+3,000
New +$211K
JHD
127
DELISTED
Nuveen High Income December 2019 Target Term Fund
JHD
$226K 0.05%
+22,562
New +$227K
IBKR icon
128
Interactive Brokers
IBKR
$40.9B
$225K 0.05%
15,200
-4,000
-21% -$54.5K
T icon
129
AT&T
T
$165B
$209K 0.05%
+7,122
New +$194K
DEST
130
DELISTED
Destination Maternity Corporation
DEST
$193K 0.04%
+65,000
New +$164K
NTLA icon
131
Intellia Therapeutics
NTLA
$1.5B
$192K 0.04%
+10,000
New +$231K
KDMN
132
DELISTED
Kadmon Holdings, Inc.
KDMN
$187K 0.04%
+51,730
New +$185K
MNKD icon
133
MannKind Corp
MNKD
$1.28B
$183K 0.04%
+78,665
New +$269K
PFO
134
Flaherty & Crumrine Preferred and Income Opportunity Fund
PFO
$118M
$178K 0.04%
+15,105
New +$182K
ARWR icon
135
Arrowhead Research
ARWR
$12.1B
$175K 0.04%
+47,683
New +$177K
CYRX icon
136
CryoPort
CYRX
$775M
$167K 0.04%
+19,495
New +$153K
AUD
137
DELISTED
Audacy, Inc.
AUD
$163K 0.04%
15,066
-37,434
-71% -$426K
VKTX icon
138
Viking Therapeutics
VKTX
$4.04B
$162K 0.04%
+40,000
New +$116K
SENS icon
139
Senseonics Holdings Inc
SENS
$254M
$154K 0.04%
+2,896
New +$161K
PMO
140
Franklin Municipal Opportunities Trust
PMO
$282M
$152K 0.03%
+12,298
New +$154K
MARK
141
DELISTED
Remark Holdings, Inc.
MARK
$147K 0.03%
+1,514
New +$89.4K
SRNE
142
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$144K 0.03%
+37,882
New +$98.7K
QHC
143
DELISTED
Quorum Health Corporation
QHC
$144K 0.03%
+23,117
New +$116K
ECYT
144
DELISTED
Endocyte, Inc. Common Stock
ECYT
$144K 0.03%
+33,675
New +$160K
VCEL icon
145
Vericel Corp
VCEL
$2.3B
$141K 0.03%
+25,874
New +$119K
CGI
146
DELISTED
Celadon Group Inc
CGI
$135K 0.03%
+21,022
New +$138K
ENPH icon
147
Enphase Energy
ENPH
$4.84B
$132K 0.03%
+54,822
New +$115K
IMUX icon
148
Immunic
IMUX
$182M
$130K 0.03%
+55
New +$122K
NAGE
149
Niagen Bioscience
NAGE
$256M
$122K 0.03%
+20,680
New +$112K
CTSO icon
150
Cytosorbents Corp
CTSO
$22.6M
$115K 0.03%
+17,689
New +$113K

Similar funds

Alpine Global Management's Q4 2017 Portfolio in Review

As of Q4 2017, Alpine Global Management held 313 positions worth $440M, up 27% from $346M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Alpine Global Management deployed $94.5M of net new capital in Q4 2017, opening 120 new positions and adding to 42 existing holdings. Its largest new stake was Liberty Broadband Class C: 230,374 shares worth $19.6M.

By sector, the portfolio is most concentrated in Communication Services at 31% of assets, up from 23% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Scripps Networks Interactive, Inc Common Class A, an estimated $4.98M trimmed.

  • Alpine Global Management's largest Q4 2017 buy was Liberty Broadband Class C: 230,374 shares worth $19.6M.
  • Alpine Global Management added most to Alphabet (Google) Class A in Q4 2017, an estimated $42.4M increase.
  • Alpine Global Management's biggest Q4 2017 reduction was Scripps Networks Interactive, Inc Common Class A, cutting an estimated $4.98M.
  • Alpine Global Management fully exited State Street SPDR S&P 500 ETF Trust in Q4 2017, selling an estimated $22.5M.
  • Alpine Global Management's ten largest holdings make up 58% of its $440M portfolio in Q4 2017.
  • Alpine Global Management opened 120 new positions and closed 130 in Q4 2017.
  • Alpine Global Management's portfolio value rose 27% quarter-over-quarter to $440M.

Based on Alpine Global Management's 13F filing for Q4 2017, filed 14 Feb 2018.